| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium, potassium:sodium antiporter activity | 1.88e-08 | 5 | 158 | 4 | GO:0008273 | |
| GeneOntologyMolecularFunction | calcium:sodium antiporter activity | 7.64e-07 | 10 | 158 | 4 | GO:0005432 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 2.55e-06 | 13 | 158 | 4 | GO:0015368 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | VWF OBSCN LAMB1 ADAMTS13 UNC45A ITGA3 PFN1 ITGAD FASN CDH20 EIF4G2 DCHS1 PRKCA TLN2 ADAM17 PLEC CNGA3 | 5.60e-06 | 599 | 158 | 17 | GO:0050839 |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 1.33e-05 | 19 | 158 | 4 | GO:0022821 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 2.20e-05 | 43 | 158 | 5 | GO:0008307 | |
| GeneOntologyMolecularFunction | histone H3T6 kinase activity | 6.22e-05 | 2 | 158 | 2 | GO:0035403 | |
| GeneOntologyMolecularFunction | integrin binding | 7.82e-05 | 175 | 158 | 8 | GO:0005178 | |
| GeneOntologyMolecularFunction | histone H3 kinase activity | 1.01e-04 | 12 | 158 | 3 | GO:0140996 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 3.66e-04 | 43 | 158 | 4 | GO:0140828 | |
| GeneOntologyMolecularFunction | translation elongation factor activity | 5.02e-04 | 20 | 158 | 3 | GO:0003746 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 6.29e-04 | 238 | 158 | 8 | GO:0016747 | |
| GeneOntologyMolecularFunction | ankyrin binding | 7.66e-04 | 23 | 158 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | chromatin binding | TICRR MBTD1 VRK1 EP400 STAG1 RELA CHD7 MORC2 ZFX IKZF5 HNRNPU GTF2B GLI2 PRKCB KAT6B | 7.94e-04 | 739 | 158 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 8.77e-04 | 54 | 158 | 4 | GO:0030159 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | EVL FKBP15 EML4 CAPN3 ENC1 OBSCN RELA ADGRV1 PFN1 NEDD1 HNRNPU SPTBN4 PDLIM3 NAV3 TLN2 MTCL1 PLEC ARHGEF2 CNGA3 | 1.12e-03 | 1099 | 158 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | ankyrin repeat binding | 1.27e-03 | 7 | 158 | 2 | GO:0071532 | |
| GeneOntologyMolecularFunction | acyltransferase activity | RGPD2 RANBP2 LPCAT1 HECTD3 ASPG UBR4 SRCAP BRAP GTF2B FASN RNFT2 DGAT2 DLST RPGR KAT6B | 1.28e-03 | 775 | 158 | 15 | GO:0016746 |
| GeneOntologyMolecularFunction | histone kinase activity | 1.38e-03 | 28 | 158 | 3 | GO:0035173 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.43e-03 | 104 | 158 | 5 | GO:0016407 | |
| GeneOntologyMolecularFunction | cadherin binding | 1.55e-03 | 339 | 158 | 9 | GO:0045296 | |
| GeneOntologyBiologicalProcess | positive regulation of translational termination | 1.79e-06 | 4 | 159 | 3 | GO:0045905 | |
| GeneOntologyBiologicalProcess | positive regulation of translational elongation | 4.44e-06 | 5 | 159 | 3 | GO:0045901 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | EVL ARHGAP32 ENC1 EIF5A2 PUM2 RAPGEF1 SLITRK3 ICE1 SYT2 ITGA3 MORC2 PFN1 ZEB2 FAF1 GRIP1 EIF5AL1 MAVS EIF4G2 EIF5A FER NAV3 PLCB1 PRKCA ADAM17 PAN3 BECN1 INO80E | 5.63e-06 | 1366 | 159 | 27 | GO:0051130 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | SHANK1 EVL WASHC4 MYOM1 EML4 CAPN3 OBSCN COL5A3 PFN1 NEDD1 SELENON ZEB2 SPTBN4 COL18A1 RHOBTB1 PDLIM3 FER NAV3 PLEC ARHGEF2 BBLN | 1.52e-05 | 957 | 159 | 21 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 1.62e-05 | 144 | 159 | 8 | GO:0043244 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental growth | ARHGAP32 CAPN3 PUM2 CHD7 SYT2 TRIP10 SPTBN4 TGFBR3 EIF4G2 PLCB1 | 1.65e-05 | 238 | 159 | 10 | GO:0048639 |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | EVL EML4 VPS33A EIF5A2 NEDD1 SPTBN4 EIF5AL1 EIF5A NAV3 ARHGEF2 BECN1 | 1.66e-05 | 291 | 159 | 11 | GO:0032984 |
| GeneOntologyBiologicalProcess | cellular component disassembly | EVL VRK1 EML4 VPS33A EIF5A2 NEDD1 SPTBN4 EIF5AL1 EIF5A FER NAV3 PRKCA C1QC PRKCB ARHGEF2 BECN1 | 2.37e-05 | 617 | 159 | 16 | GO:0022411 |
| GeneOntologyBiologicalProcess | mitotic nuclear membrane disassembly | 2.45e-05 | 8 | 159 | 3 | GO:0007077 | |
| GeneOntologyBiologicalProcess | insulin receptor signaling pathway | 2.89e-05 | 156 | 159 | 8 | GO:0008286 | |
| GeneOntologyBiologicalProcess | regulation of translational termination | 3.65e-05 | 9 | 159 | 3 | GO:0006449 | |
| GeneOntologyBiologicalProcess | neuron development | SHANK1 EVL ARHGAP32 VRK1 ENC1 LAMB1 PUM2 RAPGEF1 SLITRK3 FRYL SYT2 ADGRV1 ITGA3 ZEB2 GRIP1 SPTBN4 SEMA3D GLI2 RP1L1 EIF4G2 PRKCA ADAM17 RPGR BECN1 CNGA3 SEZ6 | 5.35e-05 | 1463 | 159 | 26 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of growth | ARHGAP32 CAPN3 PUM2 CHD7 SYT2 TRIP10 SPTBN4 TGFBR3 EIF4G2 PLCB1 ADAM17 | 6.68e-05 | 339 | 159 | 11 | GO:0045927 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | MYOM1 STAG1 CAPN3 OBSCN PUM2 HNRNPU CIRBP GTF2B PLEC PAN3 ARHGEF2 BECN1 YTHDF2 | 8.29e-05 | 475 | 159 | 13 | GO:0140694 |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | CAPN3 SLC24A3 CHD7 SELENON SLC24A4 SLC24A2 PLCB1 UMOD PRKCA PRKCB SLC24A1 | 1.11e-04 | 359 | 159 | 11 | GO:0006874 |
| GeneOntologyBiologicalProcess | cell cycle process | TICRR MBTPS1 VRK1 STAG1 IFFO1 EML4 CAPN3 PUM2 MORC2 HNRNPU CABLES1 CIRBP GTF2B TLK1 PLCB1 PRKCA PRKCB GNAI1 ADAM17 MTCL1 PLEC ARHGEF2 BECN1 YTHDF2 SON | 1.11e-04 | 1441 | 159 | 25 | GO:0022402 |
| GeneOntologyBiologicalProcess | nuclear membrane disassembly | 1.21e-04 | 13 | 159 | 3 | GO:0051081 | |
| GeneOntologyBiologicalProcess | membrane disassembly | 1.54e-04 | 14 | 159 | 3 | GO:0030397 | |
| GeneOntologyBiologicalProcess | regulation of translational elongation | 1.54e-04 | 14 | 159 | 3 | GO:0006448 | |
| GeneOntologyBiologicalProcess | response to water | 1.54e-04 | 14 | 159 | 3 | GO:0009415 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | SHANK1 EVL WASHC4 MYOM1 CAPN3 OBSCN PFN1 TRIP10 SH2B2 ZEB2 SPTBN4 RHOBTB1 PDLIM3 FER TLN2 PLEC ARHGEF2 | 1.60e-04 | 803 | 159 | 17 | GO:0030036 |
| GeneOntologyBiologicalProcess | stress granule assembly | 1.65e-04 | 36 | 159 | 4 | GO:0034063 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 1.73e-04 | 151 | 159 | 7 | GO:0045727 | |
| GeneOntologyBiologicalProcess | organelle assembly | ABCC4 MYOM1 STAG1 DYNC2H1 FBF1 CAPN3 OBSCN PUM2 SLITRK3 HNRNPU CIRBP FSIP2 GTF2B RP1L1 WDR90 RPGR PLEC PAN3 ARHGEF2 BECN1 YTHDF2 | 1.81e-04 | 1138 | 159 | 21 | GO:0070925 |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | CAPN3 SLC24A3 CHD7 SELENON SLC24A4 SLC24A2 PLCB1 UMOD PRKCA PRKCB SLC24A1 | 2.23e-04 | 389 | 159 | 11 | GO:0055074 |
| GeneOntologyBiologicalProcess | translational termination | 2.82e-04 | 17 | 159 | 3 | GO:0006415 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | RANBP2 PDK2 UGGT1 RAPGEF1 RELA ADAMTS13 SELENON SH2B2 FAF1 TGFBR3 SLC24A4 MAVS RNFT2 FER PLCB1 UMOD PRKCA PRKCB GNAI1 IRS2 ARHGEF2 CNGA3 | 3.12e-04 | 1272 | 159 | 22 | GO:1901698 |
| GeneOntologyBiologicalProcess | central nervous system neuron axonogenesis | 3.32e-04 | 43 | 159 | 4 | GO:0021955 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | HSPD1 EGLN2 LPCAT1 CAPN3 EIF5A2 RELA ZEB2 FAF1 HNRNPU CIRBP EIF5AL1 MAPK12 MAVS RNFT2 SERPINB3 EIF4G2 EIF5A PLCB1 PRKCA ADAM17 ARHGEF2 PIK3R5 TNFSF15 YTHDF2 | 3.38e-04 | 1458 | 159 | 24 | GO:0051247 |
| GeneOntologyBiologicalProcess | cell morphogenesis | SHANK1 EVL ARHGAP32 VPS33A LAMB1 SLITRK3 FRYL SYT2 ZEB2 GRIP1 SPTBN4 COL18A1 SEMA3D CDH20 GLI2 EIF4G2 PRKCA ADAM17 PLEC ARHGEF2 YTHDF2 | 3.46e-04 | 1194 | 159 | 21 | GO:0000902 |
| GeneOntologyBiologicalProcess | muscle structure development | MYOM1 CAPN3 OBSCN LAMB1 CHD7 UNC45A SELENON TRIP10 HNRNPU TGFBR3 EIF5AL1 MAPK12 PDLIM3 EIF5A PLCB1 TANC1 PLEC | 3.47e-04 | 858 | 159 | 17 | GO:0061061 |
| GeneOntologyBiologicalProcess | neuron projection development | SHANK1 EVL ARHGAP32 VRK1 ENC1 LAMB1 PUM2 RAPGEF1 SLITRK3 FRYL SYT2 ADGRV1 ITGA3 ZEB2 GRIP1 SPTBN4 SEMA3D GLI2 EIF4G2 PRKCA ADAM17 SEZ6 | 3.59e-04 | 1285 | 159 | 22 | GO:0031175 |
| GeneOntologyCellularComponent | annulate lamellae | 3.12e-06 | 14 | 160 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | cone photoreceptor outer segment | 6.94e-05 | 11 | 160 | 3 | GO:0120199 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 9.89e-05 | 139 | 160 | 7 | GO:0097733 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | RGPD2 RANBP2 HECTD3 VPS33A LAMB1 PUM2 RAPGEF1 ADGRV1 UNC45A ITGA3 SRCAP TRIP10 FAF1 GRIP1 DGAT2 PRKCA PLEC GOLGA1 SEZ6 | 9.97e-05 | 934 | 160 | 19 | GO:0048471 |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 1.80e-04 | 153 | 160 | 7 | GO:0097731 | |
| GeneOntologyCellularComponent | photoreceptor outer segment | 2.14e-04 | 111 | 160 | 6 | GO:0001750 | |
| GeneOntologyCellularComponent | striated muscle myosin thick filament | 3.46e-04 | 4 | 160 | 2 | GO:0005863 | |
| GeneOntologyCellularComponent | anchoring junction | EVL FBF1 OBSCN ITGA3 PFN1 LAP3 SPTBN4 CDH20 PDLIM3 EIF4G2 CPNE3 FER PRKCA TLN2 ADAM17 PLEC ARHGEF2 BBLN | 5.01e-04 | 976 | 160 | 18 | GO:0070161 |
| GeneOntologyCellularComponent | cell cortex | ARHGAP32 FRYL PFN1 TRIP10 DENND2B GRIP1 SPTBN4 FER PRKCB GNAI1 | 5.93e-04 | 371 | 160 | 10 | GO:0005938 |
| GeneOntologyCellularComponent | supramolecular fiber | MYOM1 DYNC2H1 IFFO1 EML4 FBF1 CAPN3 OBSCN COL5A3 TRIP10 SH2B2 HNRNPU GRIP1 SPTBN4 PDLIM3 RP1L1 NAV3 MTCL1 PLEC ARHGEF2 BBLN | 6.97e-04 | 1179 | 160 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | nuclear matrix | 7.39e-04 | 140 | 160 | 6 | GO:0016363 | |
| GeneOntologyCellularComponent | supramolecular polymer | MYOM1 DYNC2H1 IFFO1 EML4 FBF1 CAPN3 OBSCN COL5A3 TRIP10 SH2B2 HNRNPU GRIP1 SPTBN4 PDLIM3 RP1L1 NAV3 MTCL1 PLEC ARHGEF2 BBLN | 7.58e-04 | 1187 | 160 | 20 | GO:0099081 |
| GeneOntologyCellularComponent | non-motile cilium | 7.98e-04 | 196 | 160 | 7 | GO:0097730 | |
| GeneOntologyCellularComponent | ooplasm | 8.56e-04 | 6 | 160 | 2 | GO:1990917 | |
| GeneOntologyCellularComponent | INO80-type complex | 1.25e-03 | 28 | 160 | 3 | GO:0097346 | |
| GeneOntologyCellularComponent | cilium | HSPD1 ABCC4 DYNC2H1 FBF1 ADGRV1 NEDD1 FSIP2 SLC24A4 GLI2 RP1L1 UMOD PRKCA RPGR CNGA3 PHLPP2 DRC3 | 1.48e-03 | 898 | 160 | 16 | GO:0005929 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | DYNC2H1 IFFO1 EML4 FBF1 TRIP10 SH2B2 HNRNPU GRIP1 SPTBN4 PDLIM3 RP1L1 NAV3 MTCL1 PLEC ARHGEF2 BBLN | 1.50e-03 | 899 | 160 | 16 | GO:0099513 |
| GeneOntologyCellularComponent | nuclear body | MAGEA11 VRK1 EP400 STAG1 PSMB7 OBSCN ICE1 UNC45A SRCAP HNRNPU SPTBN4 GTF2B GLI2 PLCB1 BECN1 SON | 1.57e-03 | 903 | 160 | 16 | GO:0016604 |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.58e-03 | 8 | 160 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | intercalated disc | 1.84e-03 | 68 | 160 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 2.00e-03 | 230 | 160 | 7 | GO:0019898 | |
| GeneOntologyCellularComponent | spectrin | 2.02e-03 | 9 | 160 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | nuclear periphery | 2.06e-03 | 171 | 160 | 6 | GO:0034399 | |
| HumanPheno | Anal stenosis | 2.62e-06 | 34 | 62 | 6 | HP:0002025 | |
| Domain | K/Na/Ca-exchanger | 2.51e-08 | 5 | 159 | 4 | IPR004481 | |
| Domain | IF5A_HYPUSINE | 6.05e-07 | 3 | 159 | 3 | PS00302 | |
| Domain | Transl_elong_IF5A_C | 6.05e-07 | 3 | 159 | 3 | IPR020189 | |
| Domain | Transl_elong_IF5A | 6.05e-07 | 3 | 159 | 3 | IPR001884 | |
| Domain | eIF-5a | 6.05e-07 | 3 | 159 | 3 | PF01287 | |
| Domain | Trans_elong_IF5A_hypusine_site | 6.05e-07 | 3 | 159 | 3 | IPR019769 | |
| Domain | eIF-5a | 6.05e-07 | 3 | 159 | 3 | SM01376 | |
| Domain | NaCa_Exmemb | 6.16e-07 | 9 | 159 | 4 | IPR004837 | |
| Domain | Na_Ca_ex | 6.16e-07 | 9 | 159 | 4 | PF01699 | |
| Domain | Collagenase_NC10/endostatin | 7.20e-05 | 2 | 159 | 2 | IPR010515 | |
| Domain | Endostatin | 7.20e-05 | 2 | 159 | 2 | PF06482 | |
| Domain | Protein_kinase_C_a/b/g | 2.15e-04 | 3 | 159 | 2 | IPR014375 | |
| Domain | Translation_prot_SH3-like | 3.77e-04 | 17 | 159 | 3 | IPR008991 | |
| Domain | HSA | 4.27e-04 | 4 | 159 | 2 | SM00573 | |
| Domain | FERM_f0 | 4.27e-04 | 4 | 159 | 2 | PF16511 | |
| Domain | HSA | 4.27e-04 | 4 | 159 | 2 | PS51204 | |
| Domain | FERM_f0 | 4.27e-04 | 4 | 159 | 2 | IPR032425 | |
| Domain | HSA_dom | 4.27e-04 | 4 | 159 | 2 | IPR014012 | |
| Domain | HSA | 4.27e-04 | 4 | 159 | 2 | PF07529 | |
| Domain | Rib_L2_dom2 | 4.50e-04 | 18 | 159 | 3 | IPR014722 | |
| Domain | - | 4.50e-04 | 18 | 159 | 3 | 2.30.30.30 | |
| Pathway | BIOCARTA_PKC_PATHWAY | 2.52e-07 | 7 | 132 | 4 | M22057 | |
| Pathway | BIOCARTA_PKC_PATHWAY | 2.52e-07 | 7 | 132 | 4 | MM1572 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 2.30e-06 | 11 | 132 | 4 | M27336 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 4.92e-06 | 13 | 132 | 4 | MM15078 | |
| Pathway | REACTOME_HYPUSINE_SYNTHESIS_FROM_EIF5A_LYSINE | 7.92e-06 | 5 | 132 | 3 | MM14823 | |
| Pathway | BIOCARTA_CDMAC_PATHWAY | 9.26e-06 | 15 | 132 | 4 | MM1358 | |
| Pathway | BIOCARTA_CDMAC_PATHWAY | 1.23e-05 | 16 | 132 | 4 | M4388 | |
| Pathway | BIOCARTA_ERBB4_PATHWAY | 2.73e-05 | 7 | 132 | 3 | M22043 | |
| Pathway | BIOCARTA_ERBB4_PATHWAY | 2.73e-05 | 7 | 132 | 3 | MM1563 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 6.47e-05 | 9 | 132 | 3 | M22029 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 6.47e-05 | 9 | 132 | 3 | MM1551 | |
| Pathway | BIOCARTA_EIF4_PATHWAY | 6.75e-05 | 24 | 132 | 4 | M4791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY | 9.18e-05 | 10 | 132 | 3 | M47644 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.06e-04 | 199 | 132 | 9 | M7253 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | VWF COL15A1 CAPN3 LAMB1 COL5A3 ITGA3 ITGAD COL18A1 PRKCA ADAM17 PLEC | 1.19e-04 | 300 | 132 | 11 | M610 |
| Pathway | KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY | 1.25e-04 | 11 | 132 | 3 | M47637 | |
| Pathway | BIOCARTA_MYOSIN_PATHWAY | 1.25e-04 | 11 | 132 | 3 | M7014 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY | 1.66e-04 | 12 | 132 | 3 | M47649 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY | 1.66e-04 | 12 | 132 | 3 | M47628 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.14e-04 | 13 | 132 | 3 | M47656 | |
| Pathway | WP_FOCAL_ADHESION | 3.75e-04 | 187 | 132 | 8 | MM15913 | |
| Pathway | BIOCARTA_SPPA_PATHWAY | 4.11e-04 | 16 | 132 | 3 | M8731 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 4.96e-04 | 17 | 132 | 3 | MM15584 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 4.96e-04 | 17 | 132 | 3 | M5488 | |
| Pathway | WP_FOCAL_ADHESION | 5.67e-04 | 199 | 132 | 8 | M39402 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.69e-04 | 41 | 132 | 4 | M27778 | |
| Pathway | BIOCARTA_CARDIACEGF_PATHWAY | 5.91e-04 | 18 | 132 | 3 | M7552 | |
| Pathway | BIOCARTA_CARDIACEGF_PATHWAY | 5.91e-04 | 18 | 132 | 3 | MM1479 | |
| Pathway | KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION | 6.24e-04 | 42 | 132 | 4 | M16473 | |
| Pathway | PID_THROMBIN_PAR1_PATHWAY | 6.83e-04 | 43 | 132 | 4 | M238 | |
| Pathway | BIOCARTA_CCR3_PATHWAY | 6.97e-04 | 19 | 132 | 3 | MM1361 | |
| Pathway | BIOCARTA_CXCR4_PATHWAY | 6.97e-04 | 19 | 132 | 3 | MM1375 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 6.97e-04 | 19 | 132 | 3 | M47596 | |
| Pathway | BIOCARTA_PAR1_PATHWAY | 6.97e-04 | 19 | 132 | 3 | MM1514 | |
| Pathway | BIOCARTA_CXCR4_PATHWAY | 6.97e-04 | 19 | 132 | 3 | M882 | |
| Pathway | BIOCARTA_PAR1_PATHWAY | 6.97e-04 | 19 | 132 | 3 | M3494 | |
| Pathway | BIOCARTA_CCR3_PATHWAY | 6.97e-04 | 19 | 132 | 3 | M9152 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 7.24e-04 | 76 | 132 | 5 | MM14867 | |
| Pathway | BIOCARTA_EDG1_PATHWAY | 8.14e-04 | 20 | 132 | 3 | MM1456 | |
| Pathway | BIOCARTA_ION_PATHWAY | 8.54e-04 | 5 | 132 | 2 | M22059 | |
| Pathway | BIOCARTA_PLCD_PATHWAY | 8.54e-04 | 5 | 132 | 2 | M22080 | |
| Pathway | BIOCARTA_ION_PATHWAY | 8.54e-04 | 5 | 132 | 2 | MM1574 | |
| Pathway | BIOCARTA_PLCD_PATHWAY | 8.54e-04 | 5 | 132 | 2 | MM1587 | |
| Pathway | REACTOME_DISINHIBITION_OF_SNARE_FORMATION | 8.54e-04 | 5 | 132 | 2 | M26920 | |
| Pathway | WP_FOXA2_PATHWAY | 9.43e-04 | 21 | 132 | 3 | M42579 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY | 9.43e-04 | 21 | 132 | 3 | M47638 | |
| Pathway | WP_FRAGILE_X_SYNDROME | 9.59e-04 | 121 | 132 | 6 | M39804 | |
| Pathway | BIOCARTA_EDG1_PATHWAY | 1.08e-03 | 22 | 132 | 3 | M10579 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 1.18e-03 | 126 | 132 | 6 | M16763 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.20e-03 | 85 | 132 | 5 | M16441 | |
| Pathway | BIOCARTA_EIF4_PATHWAY | 1.24e-03 | 23 | 132 | 3 | MM1470 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | HSPD1 FKBP15 RANBP2 EP400 ZFYVE16 PUM2 ICE1 UNC45A SRCAP PFN1 NEDD1 ANKHD1 GFPT1 HNRNPU BRAP FASN PDLIM3 MAVS EIF4G2 CPNE3 IRS2 SIPA1L2 YTHDF2 SON | 9.69e-12 | 934 | 160 | 24 | 33916271 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | HSPD1 ARHGAP32 RANBP2 IFFO1 RELA UNC45A NEDD1 GFPT1 GRIP1 ARFGAP2 PDLIM3 MAVS EIF4G2 CPNE3 EIF5A PRKCA TANC1 PLEC PAN3 ARHGEF2 SIPA1L2 YTHDF2 | 7.15e-11 | 853 | 160 | 22 | 28718761 |
| Pubmed | 4.31e-10 | 4 | 160 | 4 | 26631410 | ||
| Pubmed | Expression of potassium-dependent sodium-calcium exchanger in the murine lens. | 2.15e-09 | 5 | 160 | 4 | 29128492 | |
| Pubmed | SHANK1 HSPD1 EVL RGPD2 FKBP15 ARHGAP32 RANBP2 PDK2 UBR4 VPS33A HNRNPU ARFGAP2 EIF5AL1 EIF4G2 EIF5A NAV3 PLCB1 PRKCA PRKCB TLN2 DLST PLEC SIPA1L2 | 2.89e-09 | 1139 | 160 | 23 | 36417873 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EVL RANBP2 LEO1 EP400 EML4 PUM2 CHD7 MORC2 AKT1S1 ZFX TLK1 FASN EIF4G2 TLN2 IRS2 PLEC ARHGEF2 KAT6B SON | 3.49e-09 | 774 | 160 | 19 | 15302935 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | HSPD1 RGPD2 RANBP2 LPCAT1 UGGT1 UBR4 UNC45A ITGA3 PFN1 SAR1A GFPT1 FASN EIF5A DLST ADAM17 PLEC YTHDF2 | 9.10e-09 | 647 | 160 | 17 | 26618866 |
| Pubmed | HSPD1 RANBP2 LEO1 MORC2 GFPT1 CABLES1 FASN MAVS PRKCA TLN2 IRS2 MTCL1 ARHGEF2 BBLN SON | 1.36e-08 | 503 | 160 | 15 | 16964243 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSPD1 RANBP2 WASHC4 EP400 EML4 UBR4 CHD7 UNC45A SRCAP PFN1 ANKHD1 GFPT1 HNRNPU FASN SERPINB3 EIF4G2 CPNE3 PRKCA DLST TANC1 PLEC ARHGEF2 YTHDF2 SON | 1.54e-08 | 1353 | 160 | 24 | 29467282 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | HSPD1 FKBP15 RANBP2 LEO1 ZFYVE16 UGGT1 UBR4 PSMB7 LAMB1 UNC45A PFN1 NEDD1 ANKHD1 GFPT1 FASN CPNE3 EIF5A GNAI1 IRS2 SIPA1L2 | 2.60e-08 | 974 | 160 | 20 | 28675297 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HSPD1 RANBP2 LPCAT1 LEO1 EML4 UGGT1 UBR4 EIF5A2 UNC45A PFN1 ANKHD1 TRIP10 GFPT1 HNRNPU CIRBP GTF2B FASN EIF4G2 EIF5A IRS2 MTCL1 PLEC ARHGEF2 SON | 3.59e-08 | 1415 | 160 | 24 | 28515276 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EP400 UBR4 OBSCN RAPGEF1 FRYL ICE1 ITGA3 SRCAP ANKHD1 SH2B2 CABLES1 TLK1 FASN TLN2 DISP2 IRS2 WDR90 TANC1 PLEC ARHGEF2 SIPA1L2 | 4.23e-08 | 1105 | 160 | 21 | 35748872 |
| Pubmed | ARHGAP32 LPCAT1 HECTD3 DYNC2H1 FBF1 UBR4 VPS33A CHD7 ITGA3 SAR1A GFPT1 PLCB1 DLST IRS2 MTCL1 ARHGEF2 | 4.84e-08 | 638 | 160 | 16 | 31182584 | |
| Pubmed | MBTD1 UGGT1 UBR4 ENC1 PUM2 TLK1 GLI2 TANC1 RPGR PLEC ARHGEF2 KAT6B | 5.65e-08 | 335 | 160 | 12 | 15741177 | |
| Pubmed | FKBP15 TOB2 MBTPS1 EP400 ZFYVE16 PUM2 ZEB2 NAV3 DISP2 CIPC MTCL1 SIPA1L2 SON | 5.92e-08 | 407 | 160 | 13 | 12693553 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RANBP2 LPCAT1 VRK1 UGGT1 UBR4 RELA FRYL PFN1 TRIP10 LAP3 GFPT1 FAF1 HNRNPU BRAP FASN MAVS SERPINB3 EIF4G2 EIF5A PRKCA DLST GNAI1 SON | 8.25e-08 | 1367 | 160 | 23 | 32687490 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | HSPD1 RANBP2 VRK1 STAG1 VPS33A CHD7 UNC45A FAF1 HNRNPU FASN CPNE3 TLN2 MTCL1 PLEC ARHGEF2 | 9.12e-08 | 582 | 160 | 15 | 20467437 |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 11161802 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 36848144 | ||
| Pubmed | Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells. | 9.56e-08 | 3 | 160 | 3 | 16519677 | |
| Pubmed | SHANK1 RGPD2 FKBP15 ARHGAP32 RANBP2 UBR4 CHD7 ZEB2 HNRNPU SPTBN4 DCHS1 PLCB1 PRKCA PRKCB TLN2 GNAI1 MTCL1 ARHGEF2 GOLGA1 | 1.10e-07 | 963 | 160 | 19 | 28671696 | |
| Pubmed | HSPD1 EVL RGPD2 RANBP2 LEO1 WDR4 STAG1 UGGT1 FBF1 UBR4 HKDC1 SRCAP ZEB2 HNRNPU SPTBN4 TLK1 FASN DGAT2 DLST GNAI1 PLEC ARHGEF2 SIPA1L2 | 2.13e-07 | 1442 | 160 | 23 | 35575683 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | HSPD1 DYNC2H1 UGGT1 UBR4 VPS33A EIF5A2 COL5A3 SRCAP PFN1 SAR1A GFPT1 HNRNPU FASN PDLIM3 CPNE3 EIF5A PLEC | 2.17e-07 | 807 | 160 | 17 | 30575818 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EVL MBTPS1 ABCC4 WDR4 ENC1 OBSCN SLITRK3 FRYL SYT2 ADGRV1 NEDD1 SELENON DENND2B FAF1 HNRNPU SPTBN4 COL18A1 TLK1 INTS2 GLI2 TANC1 PAN3 KAT6B | 3.72e-07 | 1489 | 160 | 23 | 28611215 |
| Pubmed | SHANK1 EGLN2 VWF WASHC4 LEO1 WDR4 STAG1 UBR4 ENC1 LAMB1 ZEB2 GFPT1 FAF1 SPTBN4 EIF4G2 NAV3 TLN2 DLST CIPC PLEC BECN1 | 5.11e-07 | 1285 | 160 | 21 | 35914814 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ARHGAP32 FRYL UNC45A DENND2B AKT1S1 GRIP1 FSIP2 ARFGAP2 IRS2 TANC1 MTCL1 PLEC PAN3 ARHGEF2 SIPA1L2 BECN1 YTHDF2 | 5.33e-07 | 861 | 160 | 17 | 36931259 |
| Pubmed | HSPD1 RANBP2 STAG1 UBR4 UNC45A HNRNPU FASN INTS2 SERPINB3 PLEC | 5.90e-07 | 272 | 160 | 10 | 31010829 | |
| Pubmed | RGPD2 RANBP2 ZFYVE16 UBR4 ICE1 CHD7 UNC45A ANKHD1 ZEB2 FASN IRS2 PLEC | 6.04e-07 | 418 | 160 | 12 | 34709266 | |
| Pubmed | EGLN2 VWF WASHC4 STAG1 ZFYVE16 UBR4 UNC45A DENND2B ZEB2 FAF1 GRIP1 EIF4G2 PLEC SON | 6.83e-07 | 591 | 160 | 14 | 15231748 | |
| Pubmed | SHANK1 HSPD1 EVL ARHGAP32 VWF EIF5A2 PFN1 HNRNPU SPTBN4 FASN SLC24A2 EIF4G2 PRKCA C1QC PRKCB TLN2 DLST GNAI1 TANC1 PLEC ARHGEF2 SIPA1L2 | 7.42e-07 | 1431 | 160 | 22 | 37142655 | |
| Pubmed | Biological Relevance and Therapeutic Potential of the Hypusine Modification System. | 9.49e-07 | 5 | 160 | 3 | 26037925 | |
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 20392936 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HSPD1 WASHC4 LEO1 WDR4 HECTD3 UGGT1 UBR4 PSMB7 LAMB1 RELA FRYL UNC45A TRIP10 AKT1S1 LAP3 GFPT1 FAF1 HNRNPU FASN EIF5A PLEC YTHDF2 | 9.76e-07 | 1455 | 160 | 22 | 22863883 |
| Pubmed | EVL MBTD1 LPCAT1 EML4 HKDC1 FRYL UNC45A SAR1A CIRBP ARFGAP2 RP1L1 NAV3 PRKCA PLEC SLC24A1 PIK3R5 PHLPP2 SEZ6 | 9.98e-07 | 1006 | 160 | 18 | 15226823 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | RANBP2 VRK1 WASHC4 STAG1 UBR4 MORC2 ANKHD1 TRIP10 LAP3 GFPT1 HNRNPU FASN CPNE3 YTHDF2 SON | 1.01e-06 | 704 | 160 | 15 | 29955894 |
| Pubmed | HSPD1 ARHGAP32 RANBP2 ZFYVE16 UNC45A PFN1 GFPT1 HNRNPU GRIP1 ARFGAP2 FASN EIF4G2 EIF5A IRS2 YTHDF2 | 1.08e-06 | 708 | 160 | 15 | 39231216 | |
| Pubmed | Sodium/calcium exchanger expression in the mouse and rat olfactory systems. | 1.89e-06 | 6 | 160 | 3 | 17311327 | |
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | ZFYVE16 PFN1 NEDD1 ANKHD1 ARFGAP2 PDLIM3 EIF4G2 FER TANC1 YTHDF2 | 2.69e-06 | 322 | 160 | 10 | 39098523 |
| Pubmed | TICRR MBTD1 UGGT1 ENC1 OBSCN FRYL CHD7 SRCAP ANKHD1 CDCP1 COL18A1 INTS2 EIF4G2 CPNE3 CIPC ADAM17 PLEC PAN3 | 2.85e-06 | 1084 | 160 | 18 | 11544199 | |
| Pubmed | SHANK1 HSPD1 ARHGAP32 RANBP2 VWF LAMB1 RAPGEF1 RELA TLK1 NAV3 PLCB1 PLEC | 2.88e-06 | 486 | 160 | 12 | 20936779 | |
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 22114345 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 3.53e-06 | 332 | 160 | 10 | 32786267 | |
| Pubmed | Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. | 3.56e-06 | 137 | 160 | 7 | 37039823 | |
| Pubmed | MBTD1 RANBP2 VWF MYOM1 CAPN3 OBSCN FAF1 PDLIM3 EIF4G2 CIPC PLEC SON | 3.62e-06 | 497 | 160 | 12 | 23414517 | |
| Pubmed | FKBP15 RANBP2 VRK1 LEO1 EP400 UBR4 PSMB7 UNC45A MORC2 GFPT1 GTF2B FASN EIF4G2 CPNE3 EIF5A PLEC SON | 4.82e-06 | 1014 | 160 | 17 | 32416067 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | HSPD1 VWF COL15A1 DYNC2H1 ADGRV1 ITGA3 PFN1 TRIP10 LAP3 TGFBR3 COL18A1 FASN SERPINB3 CPNE3 UMOD PRKCA GNAI1 | 4.95e-06 | 1016 | 160 | 17 | 19056867 |
| Pubmed | A single-cell time-lapse of mouse prenatal development from gastrula to birth. | 5.06e-06 | 25 | 160 | 4 | 38355799 | |
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 18632858 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | HSPD1 RANBP2 LAMB1 CHD7 MORC2 PFN1 SAR1A HNRNPU FASN EIF5A DLST GNAI1 PLEC | 7.21e-06 | 626 | 160 | 13 | 33644029 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 7.35e-06 | 361 | 160 | 10 | 26167880 | |
| Pubmed | RANBP2 EML4 UBR4 PSMB7 UNC45A ANKHD1 LAP3 GFPT1 FASN EIF4G2 CPNE3 YTHDF2 | 7.49e-06 | 534 | 160 | 12 | 35032548 | |
| Pubmed | FKBP15 IFFO1 FBF1 FRYL AKT1S1 GRIP1 GFOD1 IRS2 MTCL1 ARHGEF2 SIPA1L2 | 7.65e-06 | 446 | 160 | 11 | 24255178 | |
| Pubmed | HSPD1 EVL FKBP15 RANBP2 ABCC4 LPCAT1 BET1 EML4 UBR4 PFN1 HNRNPU FASN INTS2 EIF4G2 EIF5A DLST ADAM17 PIGO | 7.92e-06 | 1168 | 160 | 18 | 19946888 | |
| Pubmed | 8.18e-06 | 288 | 160 | 9 | 23383273 | ||
| Pubmed | FKBP15 EP400 ZFYVE16 UGGT1 PUM2 ICE1 CHD7 NEDD1 SAR1A BRAP MAVS TANC1 ARHGEF2 YTHDF2 | 8.19e-06 | 733 | 160 | 14 | 34672954 | |
| Pubmed | HSPD1 ZFYVE16 UGGT1 UBR4 VPS33A LAMB1 UNC45A ITGA3 PFN1 NEDD1 ANKHD1 GFPT1 HNRNPU COL18A1 FASN EIF5A MTCL1 PIGO YTHDF2 | 8.93e-06 | 1297 | 160 | 19 | 33545068 | |
| Pubmed | HSPD1 RGPD2 FKBP15 RANBP2 UBR4 PFN1 GFPT1 HNRNPU FASN SERPINB3 EIF4G2 CPNE3 EIF5A PLEC YTHDF2 | 9.07e-06 | 844 | 160 | 15 | 25963833 | |
| Pubmed | 9.37e-06 | 29 | 160 | 4 | 22613833 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | HSPD1 FKBP15 RANBP2 VRK1 EP400 CHD7 SRCAP HNRNPU CIRBP CPNE3 DLST PLEC PAN3 ARHGEF2 SIPA1L2 PIK3R5 SON | 1.12e-05 | 1082 | 160 | 17 | 38697112 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ARHGAP32 ZFYVE16 UNC45A PFN1 ARFGAP2 FASN MAVS EIF4G2 EIF5A ADAM17 TANC1 PLEC | 1.31e-05 | 565 | 160 | 12 | 25468996 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.37e-05 | 475 | 160 | 11 | 31040226 | |
| Pubmed | 1.53e-05 | 11 | 160 | 3 | 11104762 | ||
| Pubmed | MBTD1 LPCAT1 EP400 HECTD3 FBF1 LAMB1 ITGA3 SRCAP ANKHD1 GFOD1 ADAM17 IRS2 TANC1 SIPA1L2 KAT6B SON INO80E | 1.67e-05 | 1116 | 160 | 17 | 31753913 | |
| Pubmed | HSPD1 ZFYVE16 BET1 UGGT1 PUM2 AKT1S1 COL18A1 ARFGAP2 GTF2B PDLIM3 MAVS EIF4G2 EIF5A PAN3 PIGO YTHDF2 | 1.80e-05 | 1007 | 160 | 16 | 34597346 | |
| Pubmed | 1.84e-05 | 70 | 160 | 5 | 21726808 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MBTD1 LEO1 EP400 DYNC2H1 CHD7 SRCAP PFN1 BRAP EIF5AL1 CPNE3 TANC1 SIPA1L2 | 1.95e-05 | 588 | 160 | 12 | 38580884 |
| Pubmed | ARHGAP32 WDR4 PSMB7 LAMB1 EIF5A2 SYT2 GFPT1 CIRBP FASN PLEC SIPA1L2 | 2.05e-05 | 496 | 160 | 11 | 31343991 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 2.10e-05 | 248 | 160 | 8 | 24006456 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28102428 | ||
| Pubmed | Double knockout mice reveal a lack of major functional compensation between collagens XV and XVIII. | 2.10e-05 | 2 | 160 | 2 | 14614990 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 17296575 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 37047039 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 32065383 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 26660275 | ||
| Pubmed | ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia/reperfusion injury in mice. | 2.10e-05 | 2 | 160 | 2 | 22983446 | |
| Pubmed | N-Glycans of ADAMTS13 modulate its secretion and von Willebrand factor cleaving activity. | 2.10e-05 | 2 | 160 | 2 | 18981290 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15975930 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 21779388 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25201004 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25010251 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 16673150 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 16517978 | ||
| Pubmed | Von Willebrand factor and ADAMTS13: a candidate couple for preeclampsia pathophysiology. | 2.10e-05 | 2 | 160 | 2 | 21512165 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 26168189 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19765212 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24740645 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27444201 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24106205 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19190805 | ||
| Pubmed | Profilin 1 induces drug resistance through Beclin1 complex-mediated autophagy in multiple myeloma. | 2.10e-05 | 2 | 160 | 2 | 29945297 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19190814 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 21658591 | ||
| Pubmed | ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men. | 2.10e-05 | 2 | 160 | 2 | 17053057 | |
| Pubmed | Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients. | 2.10e-05 | 2 | 160 | 2 | 33606732 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20200350 | ||
| Pubmed | Polyamines and eIF5A Hypusination Modulate Mitochondrial Respiration and Macrophage Activation. | 2.10e-05 | 2 | 160 | 2 | 31130465 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19812385 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 29729651 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 32356431 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 16141351 | ||
| Interaction | NAA40 interactions | HSPD1 FKBP15 RANBP2 EP400 ZFYVE16 PUM2 ICE1 UNC45A SRCAP PFN1 NEDD1 ANKHD1 GFPT1 HNRNPU BRAP FASN PDLIM3 MAVS EIF4G2 CPNE3 IRS2 SIPA1L2 YTHDF2 SON | 7.43e-07 | 978 | 159 | 24 | int:NAA40 |
| Interaction | NR3C1 interactions | HSPD1 MAGEA11 ARHGAP32 LPCAT1 HECTD3 DYNC2H1 FBF1 UBR4 VPS33A RELA CHD7 ITGA3 SAR1A GFPT1 ZFX HNRNPU GRIP1 PLCB1 DLST IRS2 MTCL1 ARHGEF2 | 8.51e-06 | 974 | 159 | 22 | int:NR3C1 |
| Interaction | LYSMD4 interactions | 9.47e-06 | 6 | 159 | 3 | int:LYSMD4 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 VRK1 WASHC4 STAG1 ZFYVE16 ENC1 PUM2 FRYL DENND2B ZEB2 TGFBR3 TLK1 NAV3 PRKCA GNAI1 ADAM17 MTCL1 RPGR KAT6B SON PHLPP2 | 6.47e-08 | 856 | 160 | 21 | M4500 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | HSPD1 FKBP15 WASHC4 LEO1 STAG1 DYNC2H1 ENC1 ANKHD1 GFPT1 FAF1 BRAP TLK1 SRGN EIF4G2 EIF5A PLCB1 PLEC | 2.17e-06 | 721 | 160 | 17 | M10237 |
| Coexpression | GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP | 3.31e-05 | 200 | 160 | 8 | M5800 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN | 3.31e-05 | 200 | 160 | 8 | M9321 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN | 3.31e-05 | 200 | 160 | 8 | M8306 | |
| Coexpression | GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP | 3.31e-05 | 200 | 160 | 8 | M5763 | |
| Coexpression | DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN | 3.43e-05 | 201 | 160 | 8 | MM502 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | EVL RANBP2 EP400 IFFO1 EML4 UBR4 PUM2 RAPGEF1 FRYL ICE1 PFN1 ZEB2 HNRNPU TGFBR3 TLK1 GFOD1 SRGN EIF4G2 PRKCB KAT6B PIK3R5 BBLN SON | 3.93e-05 | 1492 | 160 | 23 | M40023 |
| Coexpression | TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL | RANBP2 EML4 UBR4 RAPGEF1 PFN1 SAR1A ZEB2 LAP3 DGAT2 SRGN EIF4G2 ADAM17 IRS2 PLEC PIK3R5 | 3.98e-05 | 724 | 160 | 15 | M41700 |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_UP | 4.60e-05 | 105 | 160 | 6 | M12602 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | 4.71e-05 | 272 | 160 | 9 | M15123 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_UP | 5.17e-05 | 213 | 160 | 8 | M14601 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | WASHC4 ZFYVE16 PUM2 FRYL DENND2B ZEB2 ZFX IKZF5 CABLES1 TGFBR3 SRGN UMOD PRKCA TANC1 MTCL1 SON | 7.20e-05 | 854 | 160 | 16 | M1533 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 7.66e-05 | 115 | 160 | 6 | M45752 | |
| Coexpression | CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP | 9.31e-05 | 39 | 160 | 4 | M13339 | |
| Coexpression | FORTSCHEGGER_PHF8_TARGETS_DN | LPCAT1 VWF DYNC2H1 IFFO1 OBSCN EIF5A2 COL5A3 ITGA3 GFPT1 TGFBR3 FER PRKCA MTCL1 PLEC PHLPP2 | 9.56e-05 | 783 | 160 | 15 | M2488 |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP | 1.04e-04 | 175 | 160 | 7 | M6690 | |
| Coexpression | WIERENGA_PML_INTERACTOME | 1.25e-04 | 42 | 160 | 4 | M2219 | |
| Coexpression | LIAO_METASTASIS | TOB2 LAMB1 HKDC1 RAPGEF1 CHD7 MORC2 TRIP10 RHOBTB1 NAV3 PLCB1 MTCL1 ARHGEF2 | 1.26e-04 | 540 | 160 | 12 | M13809 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 1.37e-04 | 43 | 160 | 4 | MM3857 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | WASHC4 STAG1 ENC1 PUM2 FRYL TLK1 PRKCA MTCL1 RPGR KAT6B PHLPP2 | 1.44e-04 | 466 | 160 | 11 | M13522 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 1.50e-04 | 44 | 160 | 4 | MM3775 | |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN | 1.51e-04 | 186 | 160 | 7 | M8175 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | HSPD1 TOB2 EGLN2 BET1 EIF5A2 ZEB2 GFPT1 ZFX IKZF5 BRAP GTF2B GNAI1 ADAM17 IRS2 ARHGEF2 | 1.63e-04 | 822 | 160 | 15 | M6782 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | HSPD1 LEO1 WDR4 DYNC2H1 ENC1 FRYL SAR1A GFPT1 FAF1 TLK1 EIF4G2 EIF5A GNAI1 | 1.71e-04 | 644 | 160 | 13 | M10501 |
| Coexpression | TABULA_MURIS_SENIS_LARGE_INTESTINE_SECRETORY_CELL_AGEING | EGLN2 BTBD6 EP400 PDK2 CHD7 PFN1 AKT1S1 LAP3 CIRBP ARFGAP2 EIF5AL1 EIF5A DLST INO80E | 1.72e-04 | 734 | 160 | 14 | MM3740 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 1.76e-04 | 85 | 160 | 5 | M10575 | |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP | 2.16e-04 | 197 | 160 | 7 | M9569 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP | 2.16e-04 | 197 | 160 | 7 | M5378 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP | 2.22e-04 | 198 | 160 | 7 | M7902 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN | 2.22e-04 | 198 | 160 | 7 | M5171 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP | 2.29e-04 | 199 | 160 | 7 | M9420 | |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN | 2.29e-04 | 199 | 160 | 7 | M5585 | |
| Coexpression | GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP | 2.36e-04 | 200 | 160 | 7 | M8310 | |
| Coexpression | GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN | 2.36e-04 | 200 | 160 | 7 | M6020 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN | 2.36e-04 | 200 | 160 | 7 | M7423 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TREG_UP | 2.36e-04 | 200 | 160 | 7 | M5737 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 2.72e-04 | 145 | 160 | 6 | M1810 | |
| Coexpression | PILON_KLF1_TARGETS_UP | VWF EIF5A2 PUM2 FRYL DENND2B TGFBR3 COL18A1 ARFGAP2 TLK1 IRS2 PAN3 | 2.78e-04 | 503 | 160 | 11 | M2226 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | VWF COL15A1 DYNC2H1 OBSCN NKX2-3 SLC24A3 COL5A3 ZEB2 TGFBR3 COL18A1 DCHS1 | 2.87e-04 | 505 | 160 | 11 | M39167 |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#3_top-relative-expression-ranked_500 | 8.27e-06 | 136 | 158 | 8 | gudmap_developingGonad_P2_testes_500_k3 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.68e-08 | 187 | 160 | 9 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.68e-08 | 194 | 160 | 9 | 69cf7c989ac355c459db13f9d4267b55adc3c174 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.78e-08 | 200 | 160 | 9 | 56d738ff019682af7f1f8cbe7b262a75dc8596d5 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.78e-08 | 200 | 160 | 9 | 7eed3d932018d6a87ce37d013883b371db55caeb | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.51e-07 | 176 | 160 | 8 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-07 | 177 | 160 | 8 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-07 | 179 | 160 | 8 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.15e-07 | 188 | 160 | 8 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.15e-07 | 188 | 160 | 8 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.15e-07 | 188 | 160 | 8 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.15e-07 | 188 | 160 | 8 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.15e-07 | 188 | 160 | 8 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.68e-07 | 191 | 160 | 8 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.68e-07 | 191 | 160 | 8 | 468b5149d1533f03521844d3cce8633d44eb6ed4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.68e-07 | 191 | 160 | 8 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-07 | 194 | 160 | 8 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-07 | 194 | 160 | 8 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.48e-07 | 195 | 160 | 8 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-07 | 196 | 160 | 8 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.70e-07 | 196 | 160 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-07 | 196 | 160 | 8 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.15e-07 | 198 | 160 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-A_(AT2)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.39e-07 | 199 | 160 | 8 | 09cf004032e5af912ee0cdde6e24ce3bcf7673cd | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.63e-07 | 200 | 160 | 8 | 9156f8fd61a833891d2f7b7fadd693b81b1e2d5a | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.63e-07 | 200 | 160 | 8 | d2422aaf807010194994db97142b9fd2e807312d | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.63e-07 | 200 | 160 | 8 | 566fe2e78e6f35399ec6aad5964f6d4d8ade82c6 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.63e-07 | 200 | 160 | 8 | 0f8e2fed93cc103b20a825d8d3e83787c5c015cc | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.63e-07 | 200 | 160 | 8 | 1d2ee63010b7b8b38bea7d3b30eebfbcdd18b967 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-06 | 166 | 160 | 7 | 9adceb746e67e955fd8b3e0984f4eed44b64a270 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 2.68e-06 | 169 | 160 | 7 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 2.79e-06 | 170 | 160 | 7 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 2.79e-06 | 170 | 160 | 7 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-06 | 171 | 160 | 7 | bdd30100b74e012eec3090799c22635aa57fa91d | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.25e-06 | 174 | 160 | 7 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.38e-06 | 175 | 160 | 7 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-06 | 184 | 160 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-06 | 184 | 160 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-06 | 184 | 160 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.87e-06 | 185 | 160 | 7 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | 10x5'-Lung-Mast|Lung / Manually curated celltypes from each tissue | 5.23e-06 | 187 | 160 | 7 | f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0 | |
| ToppCell | 10x5'-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 5.23e-06 | 187 | 160 | 7 | da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.41e-06 | 188 | 160 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-06 | 188 | 160 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_Th17_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.80e-06 | 190 | 160 | 7 | 693b223f6b94a46d935fbcb02d7a27340ce43154 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Th17_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.21e-06 | 192 | 160 | 7 | 12f7ea575da5d650c740e6060f5dab0478e563dd | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor-epi-tip_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.21e-06 | 192 | 160 | 7 | 87b60014202633a4f6d19b09a5dd9276c2edecfb | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.21e-06 | 192 | 160 | 7 | fa2420d6117d4800f60ef6a24bcf8bf54593cd1f | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.21e-06 | 192 | 160 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 6.21e-06 | 192 | 160 | 7 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 6.21e-06 | 192 | 160 | 7 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.43e-06 | 193 | 160 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 6.43e-06 | 193 | 160 | 7 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 193 | 160 | 7 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 193 | 160 | 7 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.43e-06 | 193 | 160 | 7 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.65e-06 | 194 | 160 | 7 | a8dc3336aa4ef497f6d26cede02ddac425e7c655 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.65e-06 | 194 | 160 | 7 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.65e-06 | 194 | 160 | 7 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.65e-06 | 194 | 160 | 7 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.87e-06 | 195 | 160 | 7 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | Immune-alveolar_macrophage_(MARCO_positive)|World / Lineage, Cell type, age group and donor | 6.87e-06 | 195 | 160 | 7 | f92114ef995e690a3bedc62c89c5fd6773d0d9f7 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.87e-06 | 195 | 160 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-06 | 195 | 160 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-06 | 195 | 160 | 7 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-06 | 195 | 160 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-06 | 195 | 160 | 7 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.11e-06 | 196 | 160 | 7 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-06 | 196 | 160 | 7 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-06 | 196 | 160 | 7 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-06 | 196 | 160 | 7 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.35e-06 | 197 | 160 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.35e-06 | 197 | 160 | 7 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.35e-06 | 197 | 160 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | (20)_NK_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 7.59e-06 | 198 | 160 | 7 | 178b885e56e734a4408032ea79c68163333de9b6 | |
| ToppCell | (200)_CD56+_NK_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 7.59e-06 | 198 | 160 | 7 | 459e841a01a900808707140297c89c1d6a79024f | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-06 | 198 | 160 | 7 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | remission-NK|World / disease stage, cell group and cell class | 7.59e-06 | 198 | 160 | 7 | 383ed78164ad37826100d3de6c3cc14f62e01813 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.85e-06 | 199 | 160 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | background-Kupffer_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.85e-06 | 199 | 160 | 7 | 91d229f3515d49639bcb5505e6aec4a9abade81c | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.11e-06 | 200 | 160 | 7 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.11e-06 | 200 | 160 | 7 | 7d90fcb5dfc4c9d562c93b0f9293ed12b5f4f404 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.11e-06 | 200 | 160 | 7 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.11e-06 | 200 | 160 | 7 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.11e-06 | 200 | 160 | 7 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.11e-06 | 200 | 160 | 7 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.11e-06 | 200 | 160 | 7 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.11e-06 | 200 | 160 | 7 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.11e-06 | 200 | 160 | 7 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.86e-05 | 152 | 160 | 6 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 159 | 160 | 6 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 159 | 160 | 6 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 159 | 160 | 6 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.27e-05 | 168 | 160 | 6 | 8697b40b2ec2cce68ef3beb4792eb3eff29be053 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 174 | 160 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.10e-05 | 175 | 160 | 6 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | IPF-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 4.10e-05 | 175 | 160 | 6 | b6d1e40d9339426d778481fd67ab7cbc0f6cb5b2 | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.10e-05 | 175 | 160 | 6 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | Control-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 4.24e-05 | 176 | 160 | 6 | 0c5916d63e1ada09105e46d2429b75129b7329ec | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175|Adult / Lineage, Cell type, age group and donor | 4.37e-05 | 177 | 160 | 6 | c9f269765c7d5d29caab75910e51645606ed562e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 178 | 160 | 6 | b03aa1de9d20895ebad55f6fcd6fe7a49335db5a | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A | FKBP15 ARHGAP32 MBTPS1 SAR1A BRAP RNFT2 MTCL1 QRSL1 GOLGA1 SON | 1.52e-06 | 199 | 160 | 10 | 5283_DN |
| Drug | Procainamide hydrochloride [614-39-1]; Up 200; 14.8uM; HL60; HT_HG-U133A | TOB2 COL15A1 ZFYVE16 HECTD3 IFFO1 EML4 GFPT1 TLK1 PLCB1 ADAM17 | 1.59e-06 | 200 | 160 | 10 | 1263_UP |
| Drug | ruboxistaurin | 6.71e-06 | 6 | 160 | 3 | ctd:C099154 | |
| Drug | NSC226080 | EVL FKBP15 MBTPS1 PSMB7 EIF5A2 RELA ANKHD1 BRAP TLK1 MAPK12 EIF4G2 EIF5A PRKCA PRKCB IRS2 BECN1 PIK3R5 QRSL1 | 1.04e-05 | 782 | 160 | 18 | CID000005040 |
| Drug | Merbromin [129-16-8]; Up 200; 5uM; HL60; HT_HG-U133A | 1.15e-05 | 198 | 160 | 9 | 2577_UP | |
| Drug | 16, 16-dimethylprostaglandin E2 methyl acetate solution; Down 200; 10uM; PC3; HT_HG-U133A | 1.15e-05 | 198 | 160 | 9 | 6592_DN | |
| Drug | 5140203; Up 200; 15uM; MCF7; HT_HG-U133A_EA | 1.15e-05 | 198 | 160 | 9 | 908_UP | |
| Drug | WY-14643; Up 200; 100uM; PC3; HG-U133A | 1.25e-05 | 200 | 160 | 9 | 481_UP | |
| Drug | FK-506; Down 200; 1uM; MCF7; HG-U133A | 1.25e-05 | 200 | 160 | 9 | 378_DN | |
| Drug | nsc25485 | SLC24A3 RELA SLC24A4 SLC24A2 SERPINB3 PLCB1 PRKCA PRKCB DLST SLC24A1 PIK3R5 | 1.36e-05 | 312 | 160 | 11 | CID000004605 |
| Drug | Cocaine | HSPD1 TOB2 VWF COL15A1 MYOM1 UBR4 ENC1 PSMB7 OBSCN LAMB1 RELA SYT2 PFN1 SAR1A GRIP1 SLC24A4 SLC24A2 EIF5A PLCB1 PRKCA PRKCB PLEC SON PHLPP2 | 1.63e-05 | 1314 | 160 | 24 | ctd:D003042 |
| Drug | AC1L1KMJ | HSPD1 VWF LAMB1 RAPGEF1 RELA PFN1 CABLES1 SPTBN4 COL18A1 MAPK12 PRKCA PRKCB PLEC | 3.34e-05 | 476 | 160 | 13 | CID000030956 |
| Disease | Hypertrophic Cardiomyopathy | 1.30e-05 | 57 | 156 | 5 | C0007194 | |
| Disease | MARDEN-WALKER SYNDROME | 2.78e-05 | 2 | 156 | 2 | C0796033 | |
| Disease | Cryptophthalmos syndrome | 8.30e-05 | 3 | 156 | 2 | C0265233 | |
| Disease | FRASER SYNDROME 1 | 8.30e-05 | 3 | 156 | 2 | C4551480 | |
| Disease | Fraser syndrome (implicated_via_orthology) | 1.65e-04 | 4 | 156 | 2 | DOID:0090001 (implicated_via_orthology) | |
| Disease | myocardial infarction (biomarker_via_orthology) | 2.15e-04 | 160 | 156 | 6 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Myasthenic Syndromes, Congenital | 2.70e-04 | 24 | 156 | 3 | C0751882 | |
| Disease | mastiha supplement exposure measurement, blood glutathione peroxidase measurement | 2.75e-04 | 5 | 156 | 2 | EFO_0600067, EFO_0600071 | |
| Disease | Ulcerative Colitis | 3.51e-04 | 63 | 156 | 4 | C0009324 | |
| Disease | serum gamma-glutamyl transferase measurement | STAG1 EML4 NKX2-3 EIF5A2 DENND2B FAF1 GTF2B SLC24A4 SLC24A2 RP1L1 ARHGEF2 SIPA1L2 MUC6 AFG1L | 3.70e-04 | 914 | 156 | 14 | EFO_0004532 |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 3.96e-04 | 65 | 156 | 4 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | mitochondrial myopathy (implicated_via_orthology) | 4.11e-04 | 6 | 156 | 2 | DOID:699 (implicated_via_orthology) | |
| Disease | platelet crit | ABCC4 VWF STAG1 PSMB7 ADGRV1 ITGAD DENND2B CABLES1 BRAP NAV3 DCHS1 PLCB1 IRS2 PLEC | 5.53e-04 | 952 | 156 | 14 | EFO_0007985 |
| Disease | Achromatopsia | 5.73e-04 | 7 | 156 | 2 | C0152200 | |
| Disease | verbal memory measurement | 5.73e-04 | 7 | 156 | 2 | EFO_0009591 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 6.08e-04 | 128 | 156 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 6.08e-04 | 128 | 156 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 6.08e-04 | 128 | 156 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 6.08e-04 | 128 | 156 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 6.08e-04 | 128 | 156 | 5 | C0007134 | |
| Disease | forced expiratory volume, response to bronchodilator | 6.31e-04 | 445 | 156 | 9 | EFO_0004314, GO_0097366 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 6.51e-04 | 447 | 156 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | blood urea nitrogen measurement | 7.05e-04 | 452 | 156 | 9 | EFO_0004741 | |
| Disease | postherpetic neuralgia | 7.62e-04 | 8 | 156 | 2 | MONDO_0041052 | |
| Disease | attempted suicide, mood disorder | 7.62e-04 | 8 | 156 | 2 | EFO_0004247, EFO_0004321 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 7.62e-04 | 8 | 156 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | nicotine dependence | 7.91e-04 | 78 | 156 | 4 | EFO_0003768 | |
| Disease | shoulder impingement syndrome | 9.11e-04 | 36 | 156 | 3 | EFO_1001178 | |
| Disease | Disorder of eye | 9.52e-04 | 212 | 156 | 6 | C0015397 | |
| Disease | amino acid measurement | ABCC4 VRK1 VWF STAG1 ZFYVE16 ASPG LAMB1 GLI2 RP1L1 NAV3 GNAI1 | 1.00e-03 | 678 | 156 | 11 | EFO_0005134 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.17e-03 | 148 | 156 | 5 | C0279702 | |
| Disease | descending aortic diameter | 1.24e-03 | 88 | 156 | 4 | EFO_0021788 | |
| Disease | Colorectal Carcinoma | SHANK1 EVL ABCC4 OBSCN ZEB2 CABLES1 GTF2B DCHS1 PRKCB PIK3R5 PIGO | 1.32e-03 | 702 | 156 | 11 | C0009402 |
| Disease | Congenital small ears | 1.33e-03 | 41 | 156 | 3 | C0152423 | |
| Disease | beta-nerve growth factor measurement | 1.43e-03 | 42 | 156 | 3 | EFO_0008035 | |
| Disease | pro‐interleukin‐16 measurement | 1.48e-03 | 11 | 156 | 2 | EFO_0010629 | |
| Disease | N-acetylputrescine measurement | 1.77e-03 | 12 | 156 | 2 | EFO_0800127 | |
| Disease | Adenoid Cystic Carcinoma | 1.99e-03 | 100 | 156 | 4 | C0010606 | |
| Disease | matrix metalloproteinase measurement | 2.08e-03 | 13 | 156 | 2 | EFO_0004744 | |
| Disease | platelet component distribution width | VWF NKX2-3 CABLES1 COL18A1 TLK1 SLC24A4 MAVS DGAT2 PLCB1 IRS2 PLEC | 2.33e-03 | 755 | 156 | 11 | EFO_0007984 |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 2.42e-03 | 14 | 156 | 2 | cv:C2931907 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 2.54e-03 | 107 | 156 | 4 | DOID:6000 (biomarker_via_orthology) | |
| Disease | Yu-Zhi constitution type | 2.79e-03 | 15 | 156 | 2 | EFO_0007638 | |
| Disease | response to irinotecan | 2.79e-03 | 15 | 156 | 2 | EFO_0004829 | |
| Disease | Ciliopathies | 2.81e-03 | 110 | 156 | 4 | C4277690 | |
| Disease | Liver Cirrhosis, Experimental | 2.82e-03 | 774 | 156 | 11 | C0023893 | |
| Disease | pulse pressure measurement | COL15A1 DYNC2H1 PSMB7 SLC24A3 FRYL SRCAP FAF1 SPTBN4 TGFBR3 GTF2B FASN CILP2 PIEZO2 MALRD1 FER TLN2 | 2.95e-03 | 1392 | 156 | 16 | EFO_0005763 |
| Disease | mean platelet volume | ARHGAP32 VWF SLC24A3 FRYL CHD7 SRCAP PFN1 DENND2B CABLES1 TLK1 PLCB1 IRS2 PLEC | 3.08e-03 | 1020 | 156 | 13 | EFO_0004584 |
| Disease | Ischemic stroke, fibrinogen measurement | 3.11e-03 | 55 | 156 | 3 | EFO_0004623, HP_0002140 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 3.17e-03 | 16 | 156 | 2 | C0751885 | |
| Disease | isocitrate measurement | 3.17e-03 | 16 | 156 | 2 | EFO_0010505 | |
| Disease | Polydactyly | 3.51e-03 | 117 | 156 | 4 | C0152427 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 3.59e-03 | 17 | 156 | 2 | C0751883 | |
| Disease | hyperglycemia (implicated_via_orthology) | 3.59e-03 | 17 | 156 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | fibrinogen measurement, factor VII measurement | 3.61e-03 | 58 | 156 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | immature platelet measurement | 3.73e-03 | 119 | 156 | 4 | EFO_0803541 | |
| Disease | ischemia (biomarker_via_orthology) | 4.02e-03 | 18 | 156 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | reticulocyte measurement | VWF ENC1 PSMB7 ITGAD DENND2B ZEB2 FAF1 BRAP CDH20 PLCB1 TLN2 IRS2 AFG1L | 4.02e-03 | 1053 | 156 | 13 | EFO_0010700 |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 4.48e-03 | 19 | 156 | 2 | C0751884 | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 4.48e-03 | 19 | 156 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | carotid artery disease (is_marker_for) | 4.48e-03 | 19 | 156 | 2 | DOID:3407 (is_marker_for) | |
| Disease | exercise test | 4.96e-03 | 20 | 156 | 2 | EFO_0004328 | |
| Disease | PR interval | 4.97e-03 | 495 | 156 | 8 | EFO_0004462 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MAEDLGLSFGETASV | 1 | O95150 | |
| EMDSQFDSTTGFLGK | 66 | O15155 | |
| FDALQESSLDSGMSG | 921 | Q96L91 | |
| GFGFSAAAGEMSDEE | 21 | Q7Z569 | |
| GISDNGGLFVMDEDA | 121 | Q96B36 | |
| VFEGEGSATLMSANY | 226 | Q9H5V8 | |
| GSELSYFGQEGMTEV | 491 | Q96KE9 | |
| AEMTHFQAEEDGGSG | 616 | Q92974 | |
| VDGSGSGDGDMEFFL | 1821 | Q8WXG9 | |
| GLSQDSAEGLSMFTG | 436 | Q8WV93 | |
| VGGADFSAMEFLDGD | 456 | O75131 | |
| FSAMEFLDGDGGSLR | 461 | O75131 | |
| GSSAISSSDLFGDMD | 456 | Q8N6H7 | |
| QSSSEVGYDAMAGDF | 496 | P10809 | |
| SETFSFMLTGEDGSR | 761 | P78524 | |
| MMSLFGEDGNIFSEG | 6 | Q9P2D1 | |
| GLADNYTSVTGMDLG | 461 | A7MBM2 | |
| GESFIMKRGDSFLDG | 491 | Q76LX8 | |
| SEDVAGATFMAAGSS | 136 | Q8NFF2 | |
| SLGGNDELSATFLEM | 271 | P49792 | |
| AGAAEEGFMTAELAG | 111 | P63096 | |
| SDSEEMFEKTSGFGS | 776 | Q9Y4B5 | |
| MDSSGATVGLFDYNS | 246 | Q8TB72 | |
| GSGSLAAMAVFEDKF | 171 | Q99436 | |
| VTSDEGSMNAFTGRG | 356 | Q8WYB5 | |
| FDSGGISIKASANMD | 286 | P28838 | |
| FNGDTTDDFTTSMGI | 536 | Q6W4X9 | |
| GAFVLDLASGEFGTM | 1796 | Q96JQ0 | |
| DMFSLFDESGSGEVD | 386 | Q8NF37 | |
| TMDLFGGADDISSGS | 311 | Q8WVC0 | |
| SGDFGLQVSTMFSED | 26 | P43364 | |
| FEDLAISASTSLGMG | 436 | Q7Z434 | |
| YMFKNGSGDSGDSSE | 26 | Q5XG99 | |
| KESVASMGADSGDDF | 31 | Q92805 | |
| SMGADSGDDFASDGS | 36 | Q92805 | |
| SSFDDTGKSSLGDMF | 396 | Q8NHV4 | |
| ADGFLMIGIDGSEAA | 411 | Q05BQ5 | |
| NMGFSDGLYEGEFTL | 766 | Q14703 | |
| SEDVAGATFMAAGGS | 491 | O60721 | |
| ENTDFGLSMLQDSGA | 166 | Q9NYK6 | |
| GAGVISGFDMTSEAA | 316 | Q86U10 | |
| MADEIDFTTGDAGAS | 1 | Q9GZV4 | |
| GSMGFGQESDVAFAE | 2876 | Q5SZK8 | |
| SFTLIGEASDGGTME | 96 | Q14457 | |
| AAFMNYLEAEGGLGD | 611 | Q8WYA1 | |
| SSDMFNEMESEGGGI | 1691 | Q5CZC0 | |
| GLATFGYSLSGQMDV | 426 | P26006 | |
| MASDFLRGEGATSYG | 81 | Q8NG97 | |
| AFSESGEMEGFNSGL | 416 | Q8IVL0 | |
| LRTDDINSGYMTDGG | 831 | Q8IVL0 | |
| LTFIDMEGSGFGGDL | 881 | P39060 | |
| DESSMSGLAAAIAGA | 216 | Q9UI08 | |
| GSFAVIGSNLDMSEA | 2961 | O94915 | |
| MFGAGDEDDTDFLSP | 1 | Q5T1M5 | |
| TTSGMLLGEEEFSYG | 366 | Q00839 | |
| FESTSGVSASFGEML | 466 | Q9H0H0 | |
| FDMAVYLATGNVSGG | 346 | P07942 | |
| MDDGDHSSLFSGALS | 1516 | P10070 | |
| DFETGDAGASATFPM | 6 | P63241 | |
| SRNDFMGSLSFGISE | 251 | P05771 | |
| SSDALSASFNGEMLG | 731 | A7KAX9 | |
| NSGMLVDGFERTFDG | 66 | Q9H5V7 | |
| MESAIAEGGASRFSA | 1 | P78344 | |
| SEDVAGATFMAAGSS | 146 | Q9HC58 | |
| QGDLQLFSMEGFGTD | 341 | Q15119 | |
| MFSDAGSGDDALDGD | 221 | Q8NBZ0 | |
| FLDDGAGMDPSDAAS | 66 | Q9Y6X9 | |
| DFSGYAMAAAEAQGE | 436 | Q0D2I5 | |
| SQEGFSTALTMDGLF | 351 | Q13349 | |
| FMSGLSTVVAEEGGE | 1901 | Q5VST9 | |
| MDTELAESGSNFSVG | 1166 | O15439 | |
| IEDMDGGTFTISNGG | 361 | P36957 | |
| GMDGGALTDTSLTDS | 146 | Q58A45 | |
| TGDNGDYTEMAFGVA | 1066 | Q9Y4H2 | |
| DGFTGDIAIDDLSFM | 1006 | Q5VYJ5 | |
| FMEQTGALAGSEGTA | 301 | P15863 | |
| DMVGIQGSDSVFSGF | 226 | P02747 | |
| EMLFSETGGGEKYND | 2821 | Q8NCM8 | |
| SSMSGFEEGSELNGF | 11 | Q9P0R6 | |
| FEEGSELNGFEGTDM | 16 | Q9P0R6 | |
| DDGDDIMATLGFGDS | 206 | Q8TES7 | |
| GDGMDVAGLDIETSF | 616 | Q9Y2F5 | |
| DFETGDAGASATFPM | 6 | Q6IS14 | |
| TQGSLDTGSDLGDFM | 441 | Q8TDN4 | |
| DTGSDLGDFMDYDPN | 446 | Q8TDN4 | |
| LDEFAMGSGSTDGVF | 121 | Q9H0R6 | |
| SDFGMSRQEDGGVYS | 701 | P16591 | |
| QTYMFEGDGSVAGSL | 746 | Q9HBT6 | |
| DGFGEAEYAAINSML | 21 | Q9BUW7 | |
| ERGYTAQGEMFSVAD | 161 | Q5BKX5 | |
| FEAMFSGGLKESQDS | 71 | O14682 | |
| MDGFAGSLDDSISAA | 1 | Q9HC35 | |
| SGSGEASAGLMEEAL | 156 | Q96KS0 | |
| EFGVDDGEVFGMASS | 301 | Q9UNN5 | |
| GSFLFDSMYAEDSEG | 246 | Q9H069 | |
| SDMEDFGFSVADGLL | 1011 | Q9Y3R0 | |
| DSLLGMEFSGRDASG | 1596 | P49327 | |
| GGNTTEAMEDFTGGV | 221 | P20807 | |
| FESSAGIFMGNAGAT | 196 | P39059 | |
| MLAAAEGTQFSDGGE | 46 | Q8TAU0 | |
| GDDSTMGPDFRAAEY | 346 | P25940 | |
| MGLGAFCNFSTEATE | 166 | Q96PD7 | |
| YMEGASESQQGIADG | 716 | Q92834 | |
| IMGDDSSNSYFLGGV | 321 | Q96EX2 | |
| TESGGAGESQEDMFA | 31 | Q8N9I0 | |
| DGEFSMDLRTKSTGG | 81 | P07737 | |
| TSDDFCTFQMVLEGG | 216 | Q9NXC2 | |
| FFLSQSGETADTLMG | 436 | Q06210 | |
| DVTFMLSEDGSGKGA | 886 | Q2TB90 | |
| TRNDFMGSLSFGVSE | 251 | P17252 | |
| SDDVAGATFMAAGGS | 171 | Q9UI40 | |
| SLGGNDELSATFLEM | 271 | P0DJD1 | |
| GMGEALLGSEQFAET | 786 | O94933 | |
| GSAAEGSMGDLSEIS | 1326 | Q9P2F8 | |
| IAGMTFTTFDLGGHE | 66 | Q9NR31 | |
| EFGACLDGTSENGMT | 956 | Q9C0D5 | |
| GSFRVLQGMVDDGSD | 251 | Q53GG5 | |
| AAMFGGSFVESANSE | 511 | O94844 | |
| LGDMAIEGGNFTTAY | 2186 | Q6ZRS2 | |
| DIFNGDADLSGMTGS | 306 | P29508 | |
| DGQYDVMFLGTDIGT | 461 | O95025 | |
| VGSYDSFDAPSLMDG | 636 | Q9Y566 | |
| QDFDMGTLGLAYVGS | 341 | P78536 | |
| MLTDSGGGGTSFEED | 1 | Q8IWZ3 | |
| FEGSSEGTISMAEGE | 551 | Q15642 | |
| LGMAAAESDKDSGFS | 31 | Q9C0C6 | |
| FDGSSDGFSREMKAD | 1081 | Q8IUL8 | |
| MASDEGKLFVGGLSF | 1 | Q14011 | |
| AMETRGLADSGQGSF | 51 | Q16281 | |
| DDSYGVDGMDLTSQG | 616 | Q9UKI8 | |
| FDDSVDMGVVGTTAG | 1401 | Q96KV7 | |
| NISGASSDLMESFGL | 501 | Q7Z2Z1 | |
| TEAFLYVGTMLDGGD | 481 | P07911 | |
| SLFGSDFVNTFDGSM | 36 | P04275 | |
| SALAMDSFAEGVGAV | 801 | Q6ZVD8 | |
| LTSFVSGLSDGMDSG | 376 | Q8WYR1 | |
| MTYELADETTGAAGG | 971 | Q8IWN7 | |
| LMEVYGFSDSFSGVD | 586 | Q13905 | |
| STMIGKGTGAASFDE | 81 | Q00403 | |
| SGSGSGFLTEMEQDY | 106 | P10124 | |
| DGLFLFSSLDTDGDM | 71 | Q9NZV5 | |
| GYDVGAMGAEEASLT | 1796 | Q9H5I5 | |
| FVELSTDSSGAAAGM | 506 | Q53EL9 | |
| QEKFSEFASETGMAG | 1766 | Q9H254 | |
| FDSAAIIEDDSGFGM | 1241 | Q8WVM7 | |
| RFMVADDAAAGSGGS | 201 | O14492 | |
| ITEFADMLSGNAGGF | 4366 | Q15149 | |
| SVDGFMRYLSGEENG | 291 | Q9NQ66 | |
| GGFGCIYLADMNSSE | 46 | Q99986 | |
| FDATGADGTHMDGDQ | 16 | P17010 | |
| IGAAFTDDGFAMGVA | 1041 | Q2M389 | |
| EELGGLASQMTSDYG | 1881 | Q9Y4G6 | |
| GEVMAELFSGGEDSQ | 341 | Q8TEQ8 | |
| MLEGSAGADASFSSL | 346 | P57081 | |
| PFDGDLLSMESEGAF | 146 | Q96AX1 | |
| FQGELLDGAQDYMSG | 961 | O60315 | |
| LRFAMEQSFSADTGG | 4966 | Q5T4S7 | |
| GLLSGDEDFSSIADM | 526 | Q04206 | |
| SSSFDMAQVFGGGAN | 296 | Q14106 | |
| MAAGALEFSGQSGAA | 601 | P18583 | |
| GSAGGTDFSMKQFAE | 506 | Q9H3U1 | |
| ADIAEFSVGGMDFSL | 846 | Q9NYU2 | |
| GGAMIDGQSAFANET | 161 | Q9Y5A9 | |
| EKDSFQASGYSGMDV | 466 | Q03167 | |
| CEGFINTFSSNDMDG | 496 | Q7Z3T8 | |
| GGGFRDSLADMSEEL | 541 | Q5T447 | |
| DFGLARQADSEMTGY | 171 | P53778 | |
| FDVSFGREGETMSLG | 411 | P52179 |